| Traci Marie Kristofik, DO | |
|
601 E 14th St, Sedalia, MO 65301-5972 | |
| (660) 826-8833 | |
| Not Available |
| Full Name | Traci Marie Kristofik |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 8 Years |
| Location | 601 E 14th St, Sedalia, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962856963 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2019008366 (Missouri) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bothwell Regional Health Center | Sedalia, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bothwell Regional Health Center | 6103714126 | 92 |
News Archive
Liver cirrhosis is a worldwide disease with an incidence of 5 - 10% and represents a major health problem everywhere. Prognosis depends on the degree of liver damage and etiology of cirrhosis.
Researchers from Mount Sinai School of Medicine have found that post-operative radiation therapy (PORT), a controversial yet frequently administered treatment for lung cancer, may not prolong life in older people with locally advanced disease.
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Critical Path Institute's Patient-Reported Outcome Consortium announces U.S. Food and Drug Administration qualification of two new clinical outcome assessment tools: the Asthma Daytime Symptom Diary and the Asthma Nighttime Symptom Diary.
The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A/S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases. The agreement funds research at the Gladstone Center for Translational Research led by Gladstone investigator Katerina Akassoglou, PhD, and establishes the new Lundbeck Center for Neurovascular and Immuno-imaging at the Gladstone Institute of Neurological Disease.
› Verified 4 days ago
| Entity Name | Bothwell Regional Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235102690 PECOS PAC ID: 6103714126 Enrollment ID: O20040310000246 |
News Archive
Liver cirrhosis is a worldwide disease with an incidence of 5 - 10% and represents a major health problem everywhere. Prognosis depends on the degree of liver damage and etiology of cirrhosis.
Researchers from Mount Sinai School of Medicine have found that post-operative radiation therapy (PORT), a controversial yet frequently administered treatment for lung cancer, may not prolong life in older people with locally advanced disease.
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Critical Path Institute's Patient-Reported Outcome Consortium announces U.S. Food and Drug Administration qualification of two new clinical outcome assessment tools: the Asthma Daytime Symptom Diary and the Asthma Nighttime Symptom Diary.
The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A/S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases. The agreement funds research at the Gladstone Center for Translational Research led by Gladstone investigator Katerina Akassoglou, PhD, and establishes the new Lundbeck Center for Neurovascular and Immuno-imaging at the Gladstone Institute of Neurological Disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Traci Marie Kristofik, DO 601 E 14th St, Sedalia, MO 65301-5972 Ph: () - | Traci Marie Kristofik, DO 601 E 14th St, Sedalia, MO 65301-5972 Ph: (660) 826-8833 |
News Archive
Liver cirrhosis is a worldwide disease with an incidence of 5 - 10% and represents a major health problem everywhere. Prognosis depends on the degree of liver damage and etiology of cirrhosis.
Researchers from Mount Sinai School of Medicine have found that post-operative radiation therapy (PORT), a controversial yet frequently administered treatment for lung cancer, may not prolong life in older people with locally advanced disease.
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Critical Path Institute's Patient-Reported Outcome Consortium announces U.S. Food and Drug Administration qualification of two new clinical outcome assessment tools: the Asthma Daytime Symptom Diary and the Asthma Nighttime Symptom Diary.
The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A/S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases. The agreement funds research at the Gladstone Center for Translational Research led by Gladstone investigator Katerina Akassoglou, PhD, and establishes the new Lundbeck Center for Neurovascular and Immuno-imaging at the Gladstone Institute of Neurological Disease.
› Verified 4 days ago
Dr. Kenneth Najeeb Azan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1718 S Ingram Ave, Suite C, Sedalia, MO 65301 Phone: 660-827-2535 Fax: 660-826-5228 | |
David H Wuellner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1712 S Lafayette Ave, Sedalia, MO 65301 Phone: 660-827-2526 Fax: 660-827-5536 | |
Philip J Fracica, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 E 14th St, Sedalia, MO 65301 Phone: 660-827-9488 | |
Gregory A Doak, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3700 W 10th St, Suite 301, Sedalia, MO 65301 Phone: 660-827-2730 Fax: 660-827-2731 | |
Henry C. Marquez, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3700 W 10th St, Suite 200, Sedalia, MO 65301 Phone: 660-827-1771 Fax: 660-827-1422 | |
Daniel R Woolery, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1712 S Lafayette Ave, Sedalia, MO 65301 Phone: 660-827-7990 Fax: 660-827-7683 | |
William G Woolery, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1712 S Lafayette Ave, Sedalia, MO 65301 Phone: 660-827-2526 Fax: 660-827-5536 |